Cargando…
SARS-CoV-2-derived fusion inhibitor lipopeptides exhibit highly potent and broad-spectrum activity against divergent human coronaviruses
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330190/ https://www.ncbi.nlm.nih.gov/pubmed/34344868 http://dx.doi.org/10.1038/s41392-021-00698-x |
_version_ | 1783732652860243968 |
---|---|
author | Zhu, Yuanmei Yu, Danwei Hu, Yue Wu, Tong Chong, Huihui He, Yuxian |
author_facet | Zhu, Yuanmei Yu, Danwei Hu, Yue Wu, Tong Chong, Huihui He, Yuxian |
author_sort | Zhu, Yuanmei |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8330190 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-83301902021-08-04 SARS-CoV-2-derived fusion inhibitor lipopeptides exhibit highly potent and broad-spectrum activity against divergent human coronaviruses Zhu, Yuanmei Yu, Danwei Hu, Yue Wu, Tong Chong, Huihui He, Yuxian Signal Transduct Target Ther Letter Nature Publishing Group UK 2021-08-03 /pmc/articles/PMC8330190/ /pubmed/34344868 http://dx.doi.org/10.1038/s41392-021-00698-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Letter Zhu, Yuanmei Yu, Danwei Hu, Yue Wu, Tong Chong, Huihui He, Yuxian SARS-CoV-2-derived fusion inhibitor lipopeptides exhibit highly potent and broad-spectrum activity against divergent human coronaviruses |
title | SARS-CoV-2-derived fusion inhibitor lipopeptides exhibit highly potent and broad-spectrum activity against divergent human coronaviruses |
title_full | SARS-CoV-2-derived fusion inhibitor lipopeptides exhibit highly potent and broad-spectrum activity against divergent human coronaviruses |
title_fullStr | SARS-CoV-2-derived fusion inhibitor lipopeptides exhibit highly potent and broad-spectrum activity against divergent human coronaviruses |
title_full_unstemmed | SARS-CoV-2-derived fusion inhibitor lipopeptides exhibit highly potent and broad-spectrum activity against divergent human coronaviruses |
title_short | SARS-CoV-2-derived fusion inhibitor lipopeptides exhibit highly potent and broad-spectrum activity against divergent human coronaviruses |
title_sort | sars-cov-2-derived fusion inhibitor lipopeptides exhibit highly potent and broad-spectrum activity against divergent human coronaviruses |
topic | Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330190/ https://www.ncbi.nlm.nih.gov/pubmed/34344868 http://dx.doi.org/10.1038/s41392-021-00698-x |
work_keys_str_mv | AT zhuyuanmei sarscov2derivedfusioninhibitorlipopeptidesexhibithighlypotentandbroadspectrumactivityagainstdivergenthumancoronaviruses AT yudanwei sarscov2derivedfusioninhibitorlipopeptidesexhibithighlypotentandbroadspectrumactivityagainstdivergenthumancoronaviruses AT huyue sarscov2derivedfusioninhibitorlipopeptidesexhibithighlypotentandbroadspectrumactivityagainstdivergenthumancoronaviruses AT wutong sarscov2derivedfusioninhibitorlipopeptidesexhibithighlypotentandbroadspectrumactivityagainstdivergenthumancoronaviruses AT chonghuihui sarscov2derivedfusioninhibitorlipopeptidesexhibithighlypotentandbroadspectrumactivityagainstdivergenthumancoronaviruses AT heyuxian sarscov2derivedfusioninhibitorlipopeptidesexhibithighlypotentandbroadspectrumactivityagainstdivergenthumancoronaviruses |